Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii
Деполимеразы, кодируемые фагами, как стратегия борьбы с полирезистентным Acinetobacter baumannii
2024-10-24
SCID: 54.1/mhmkbpn6
Discuss with AI
Acinetobacter baumanniibiofilm disruptionmultidrug-resistant bacteriaphage-encoded depolymerasespolysaccharide degradation
Figures from the paper
Abstract (AI)
Acinetobacter baumannii , a predominant nosocomial pathogen, represents a grave threat to public health due to its multiple antimicrobial resistance. Managing patients afflicted with severe infections caused by multiple drug-resistant A. baumannii is particularly challenging, given the associated high mortality rates and unfavorable prognoses. The diminishing efficacy of antibiotics against this superbug underscores the urgent necessity for novel treatments or strategies to address this formidable issue. Bacteriophage-derived polysaccharide depolymerase enzymes present a potential approach to combating this pathogen. These enzymes target and degrade the bacterial cell’s exopolysaccharide, capsular polysaccharide, and lipopolysaccharide, thereby disrupting biofilm formation and impairing the bacteria’s defense mechanisms. Nonetheless, the narrow host range of phage depolymerases limits their therapeutic efficacy. Despite the benefits of these enzymes, phage-resistant strains have been identified, highlighting the complexity of phage-host interactions and the need for further investigation. While preliminary findings are encouraging, current investigations are limited, and clinical trials are imperative to advance this treatment approach for broader clinical applications. This review explores the potential of phage-derived depolymerase enzymes against A. baumannii infections.
Key Findings
1
Phage-derived polysaccharide depolymerases are proposed as potential treatments for multidrug-resistant Acinetobacter baumannii infections.
2
Phage-resistant A. baumannii strains have emerged, underscoring the complexity of phage-host interactions and the need for further research.
3
Preliminary results are encouraging, but limited investigations and the absence of necessary clinical trials currently restrict broader clinical application.
4
The narrow host range of phage depolymerases limits their therapeutic effectiveness against diverse A. baumannii strains.
5
These enzymes degrade exopolysaccharides, capsular polysaccharides, and lipopolysaccharides, disrupting biofilms and weakening bacterial defense mechanisms.
Research Object
Phage-encoded polysaccharide depolymerase enzymes targeting multidrug-resistant Acinetobacter baumannii infections
Research Subject
The therapeutic potential, mechanisms, host-range limitations, and phage-resistance challenges of depolymerases in disrupting A. baumannii exopolysaccharides, capsules, lipopolysaccharides, and biofilms
Publication Details
Publication Date
2024-10-24
Journal
Publisher
ISSN
Cited by
62
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai13
Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process2017
Diversity and Function of Phage Encoded Depolymerases2020
Bacteriophage-Derived Depolymerases against Bacterial Biofilm2021
Phage-Borne Depolymerases Decrease Klebsiella pneumoniae Resistance to Innate Defense Mechanisms2018
Modeling the Architecture of Depolymerase-Containing Receptor Binding Proteins in Klebsiella Phages2019
Two T7-like Bacteriophages, K5-2 and K5-4, Each Encodes Two Capsule Depolymerases: Isolation and Functional Characterization2017
Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospects2023
Phage-Derived Depolymerase as an Antibiotic Adjuvant Against Multidrug-Resistant Acinetobacter baumannii2022
DePolymerase Predictor (DePP): a machine learning tool for the targeted identification of phage depolymerases2023
Improving phage therapy by evasion of phage resistance mechanisms2023
Phage tailspike modularity and horizontal gene transfer reveals specificity towards E. coli O-antigen serogroups2023
Klebsiella phage KP34gp57 capsular depolymerase structure and function: from a serendipitous finding to the design of active mini-enzymes against K. pneumoniae2023
The Specific Capsule Depolymerase of Phage PMK34 Sensitizes Acinetobacter baumannii to Serum Killing2022